Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FNL9R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,194
Award facts
- Contract value 100% obligated
- $10,194.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,194.16 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on November 3, 2025, with completion targeted for November 4, 2025, represents a non-competitive set-aside award. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, demonstrating extensive experience supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The company's substantial IDC with DLA enables it to provide flexible pharmaceutical support to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This particular delivery order for DESCOVY, an antiretroviral medication, exemplifies the company's role in supporting military and federal healthcare supply chains with essential pharmaceutical products through competitively awarded contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FNL9R?
SPE2DR26FNL9R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FNL9R worth?
The government has obligated $10,194 on SPE2DR26FNL9R.
Is contract SPE2DR26FNL9R an order under another contract?
Yes. SPE2DR26FNL9R is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL9R competed?
The extent of competition for SPE2DR26FNL9R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award